BullishAgent BullishAgent Market EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register
Portfolio (Quarterly) Guide ↗

ExodusPoint Capital Management, LP

· CIK 0001736225
13F Portfolio $12.7B AUM Filed Feb 17, 2026 EDGAR ↗ ← All Funds
Q1 2026 Q4 2025 · All 1473 New
Page 66 of 74  ·  1,473 positions
# Ticker Company Sector Shares Value ↓ % Port Chg Shares Chg % Period Price ① Since Period ①
1301 TEX TEREX CORP NEW Industrials 5,913.0 $316K 0.00% NEW $53.38 +11.1%
1302 CGEM CULLINAN THERAPEUTICS INC Healthcare 30,487.0 $316K 0.00% NEW $10.35 +60.4%
1303 PPIH PERMA-PIPE INTL HLDGS INC Industrials 10,327.0 $314K 0.00% NEW $30.36 +7.4%
1304 GDRX GOODRX HLDGS INC Healthcare 115,584.0 $313K 0.00% NEW $2.71 +4.9%
1305 VENU HLDG CORP 37,142.0 $313K 0.00% NEW $8.42
1306 LXRX LEXICON PHARMACEUTICALS INC Healthcare 268,433.0 $309K 0.00% NEW $1.15 +88.7%
1307 AMAT CALL APPLIED MATLS INC Technology 1,200.0 $309K 0.00% NEW $257.18 +73.4%
1308 APYX APYX MEDICAL CORPORATION Healthcare 87,115.0 $305K 0.00% NEW $3.50 +13.7%
1309 EBF ENNIS INC Industrials 16,913.0 $305K 0.00% NEW $18.01 +13.5%
1310 LINEAGE CELL THERAPEUTICS IN 181,694.0 $303K 0.00% NEW $1.67
1311 FORTE BIOSCIENCES INC 11,084.0 $302K 0.00% NEW $27.27
1312 OAKTREE SPECIALTY LENDING CO 23,594.0 $301K 0.00% NEW $12.74
1313 ITRN ITURAN LOCATION AND CONTROL Technology 6,975.0 $300K 0.00% NEW $43.01 +53.3%
1314 SABR SABRE CORP Consumer Cyclical 217,735.0 $296K 0.00% NEW $1.36 +19.9%
1315 CIGI COLLIERS INTL GROUP INC Real Estate 2,000.0 $294K 0.00% NEW $147.01 -34.6%
1316 FDMT 4D MOLECULAR THERAPEUTICS IN Healthcare 39,175.0 $294K 0.00% NEW $7.50 +20.3%
1317 ANIX ANIXA BIOSCIENCES INC Healthcare 93,931.0 $293K 0.00% NEW $3.12 -11.9%
1318 TNGX TANGO THERAPEUTICS INC Healthcare 32,897.0 $291K 0.00% NEW $8.86 +125.3%
1319 GCO GENESCO INC Consumer Cyclical 11,721.0 $290K 0.00% NEW $24.77 +50.6%
1320 PROK PROKIDNEY CORP Healthcare 128,853.0 $289K 0.00% NEW $2.24 -19.9%
Page 66 of 74  ·  1,473 positions

Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.

Sector Allocation
Technology 29.6%
Healthcare 12.3%
Industrials 11.3%
Financial Services 10.0%
Consumer Cyclical 9.3%
Utilities 7.9%
Consumer Defensive 5.2%
Basic Materials 4.4%
Real Estate 3.5%
Energy 3.4%